Prediction of Alzheimer's disease using multi-variants from a Chinese genome-wide association study
Longfei Jia,Fangyu Li,Cuibai Wei,Min Zhu,Qiumin Qu,Wei Qin,Yi Tang,Luxi Shen,Yanjiang Wang,Lu Shen,Honglei Li,Dantao Peng,Lan Tan,Benyan Luo,Qihao Guo,Muni Tang,Yifeng Du,Jiewen Zhang,Junjian Zhang,Jihui Lyu,Ying Li,Aihong Zhou,Fen Wang,Changbiao Chu,Haiqing Song,Liyong Wu,Xiumei Zuo,Yue Han,Junhua Liang,Qi Wang,Hongmei Jin,Wei Wang,Yang Lü,Fang Li,Yuying Zhou,Wei Zhang,Zhengluan Liao,Qiongqiong Qiu,Yan Li,Chaojun Kong,Yan Li,Haishan Jiao,Jie Lu,Jianping Jia
DOI: https://doi.org/10.1093/brain/awaa364
IF: 14.5
2020-11-14
Brain
Abstract:Abstract Previous genome-wide association studies have identified dozens of susceptibility loci for sporadic Alzheimer’s disease, but few of these loci have been validated in longitudinal cohorts. Establishing predictive models of Alzheimer’s disease based on these novel variants is clinically important for verifying whether they have pathological functions and provide a useful tool for screening of disease risk. In the current study, we performed a two-stage genome-wide association study of 3913 patients with Alzheimer’s disease and 7593 controls and identified four novel variants (rs3777215, rs6859823, rs234434, and rs2255835; Pcombined = 3.07 × 10−19, 2.49 × 10−23, 1.35 × 10−67, and 4.81 × 10−9, respectively) as well as nine variants in the apolipoprotein E region with genome-wide significance (P < 5.0 × 10−8). Literature mining suggested that these novel single nucleotide polymorphisms are related to amyloid precursor protein transport and metabolism, antioxidation, and neurogenesis. Based on their possible roles in the development of Alzheimer’s disease, we used different combinations of these variants and the apolipoprotein E status and successively built 11 predictive models. The predictive models include relatively few single nucleotide polymorphisms useful for clinical practice, in which the maximum number was 13 and the minimum was only four. These predictive models were all significant and their peak of area under the curve reached 0.73 both in the first and second stages. Finally, these models were validated using a separate longitudinal cohort of 5474 individuals. The results showed that individuals carrying risk variants included in the models had a shorter latency and higher incidence of Alzheimer’s disease, suggesting that our models can predict Alzheimer’s disease onset in a population with genetic susceptibility. The effectiveness of the models for predicting Alzheimer’s disease onset confirmed the contributions of these identified variants to disease pathogenesis. In conclusion, this is the first study to validate genome-wide association study-based predictive models for evaluating the risk of Alzheimer’s disease onset in a large Chinese population. The clinical application of these models will be beneficial for individuals harbouring these risk variants, and particularly for young individuals seeking genetic consultation.
neurosciences,clinical neurology